• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病合并除颤器患者的室性快速心律失常:触发因素、治疗及意义

Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.

作者信息

Link Mark S, Bockstall Katy, Weinstock Jonathan, Alsheikh-Ali Alawi A, Semsarian Christopher, Estes N A Mark, Spirito Paolo, Haas Tammy S, Rowin Ethan J, Maron Martin S, Maron Barry J

机构信息

UT Southwestern Medical Center, Dallas, Texas, USA.

Mount Sinai Medical Center, New York, New York, USA.

出版信息

J Cardiovasc Electrophysiol. 2017 May;28(5):531-537. doi: 10.1111/jce.13194. Epub 2017 Mar 31.

DOI:10.1111/jce.13194
PMID:28240435
Abstract

INTRODUCTION

Triggers and ICD interventions of ventricular arrhythmias in patients with hypertrophic cardiomyopathy (HCM) offer insight into mechanisms and treatment.

METHODS AND RESULTS

Intracardiac ICD electrograms from 71 HCM patients in the HCM I and II studies were analyzed by three individuals. Rhythms were defined as VF (polymorphic ventricular arrhythmia), VT (monomorphic ventricular tachycardia), and ventricular flutter (VFL; VT ≥ 240 bpm). Physical activity and rhythm preceding the arrhythmia were ascertained. Of 149 arrhythmias, VF was present in 74, VT in 57, and VFL in 18. In those whose activity was known, moderate or intense physical activity was associated with over 50% of the tachycardias (57 of 111). Rhythms preceding ventricular arrhythmias were often sinus tachycardia (49 of 149; 33%) or rapid atrial fibrillation (7 of 149; 5%). VF and VFL were more likely preceded by supraventricular rhythms >100 bpm (30 of 68 with VF; 44%; 12 of 16 with VFL 75%, vs. 14 of 50 with VT 28%; P = 0.001). Antitachycardia pacing (ATP) was successful in 39 of 53 (74%). Multiple shocks were more often required to terminate VFL (10 of 18; 56%) compared to VF (10 of 72; 14%) and VT (2 of 25; 8%; P < 0.0001). Of arrhythmias requiring more than one shock to terminate, 16 of 22 were preceded by sinus tachycardia and/or moderate or extreme physical activity.

CONCLUSIONS

Rapid supraventricular rhythms, and at least moderate activity, frequently precede VT and VF, and when they occur in these situations often require multiple ICD shocks to restore sinus rhythm. ATP is successful in terminating VT and VFL, and should be a programmed in all HCM patients with ICDs.

摘要

引言

肥厚型心肌病(HCM)患者室性心律失常的触发因素及植入式心律转复除颤器(ICD)干预措施有助于深入了解其机制和治疗方法。

方法与结果

对HCM I和II研究中71例HCM患者的心内ICD电图由三人进行分析。心律失常类型定义为心室颤动(VF,多形性室性心律失常)、室性心动过速(VT,单形性室性心动过速)和心室扑动(VFL,VT≥240次/分钟)。确定心律失常发作前的体力活动及心律情况。在149次心律失常中,VF有74次,VT有57次,VFL有18次。在活动情况已知的患者中,超过50%的心动过速(111次中的57次)与中度或剧烈体力活动有关。室性心律失常发作前的心律常为窦性心动过速(149次中的49次,33%)或快速心房颤动(149次中的7次,5%)。VF和VFL更可能在室上性心律>100次/分钟之前出现(VF的68次中有30次,44%;VFL的16次中有12次,75%,而VT的50次中有14次,28%;P=0.001)。抗心动过速起搏(ATP)在53次中有39次成功(74%)。与VF(72次中的10次,14%)和VT(25次中的2次,8%)相比,终止VFL通常需要更多次电击(18次中的10次,56%;P<0.0001)。在需要多次电击才能终止的心律失常中,22次中有16次发作前有窦性心动过速和/或中度或剧烈体力活动。

结论

快速室上性心律以及至少中度活动常先于VT和VF出现,且在这些情况下发生时,往往需要多次ICD电击才能恢复窦性心律。ATP能成功终止VT和VFL,应纳入所有植入ICD的HCM患者的程控中。

相似文献

1
Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.肥厚型心肌病合并除颤器患者的室性快速心律失常:触发因素、治疗及意义
J Cardiovasc Electrophysiol. 2017 May;28(5):531-537. doi: 10.1111/jce.13194. Epub 2017 Mar 31.
2
Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者除颤阈值测试的预后意义
J Cardiovasc Electrophysiol. 2017 Jan;28(1):103-108. doi: 10.1111/jce.13121. Epub 2016 Dec 14.
3
Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.肥厚型心肌病患者植入除颤器后早期出现室性心动过速/颤动可由高危亚组患者解释。
Heart Rhythm. 2013 Feb;10(2):214-8. doi: 10.1016/j.hrthm.2012.10.003. Epub 2012 Oct 4.
4
Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.致心律失常性右室心肌病患者的长期随访。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):750-6. doi: 10.1111/j.1540-8167.2011.02288.x. Epub 2012 Feb 21.
5
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.肥厚型心肌病和植入式心脏复律除颤器高危患者的临床过程和生活质量。
Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005820. doi: 10.1161/CIRCEP.117.005820.
6
Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.肥厚型心肌病患者植入皮下植入式心律转复除颤器的适应证
J Cardiovasc Electrophysiol. 2015 Aug;26(8):893-899. doi: 10.1111/jce.12714.
7
QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.QRS波离散度和QTc间期与肥厚型心肌病患者的恶性室性心律失常及心源性猝死相关。
J Cardiovasc Electrophysiol. 2015 May;26(5):547-55. doi: 10.1111/jce.12629. Epub 2015 Mar 27.
8
Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者中触发除颤器干预的恶性室性心律失常发生的昼夜节律模式。
Heart Rhythm. 2009 May;6(5):599-602. doi: 10.1016/j.hrthm.2009.02.007. Epub 2009 Feb 12.
9
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
10
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome.肥厚型心肌病患者的室性心律失常:发生率、分布、预测因素和结局。
Heart Rhythm. 2023 Oct;20(10):1385-1392. doi: 10.1016/j.hrthm.2023.06.015. Epub 2023 Jun 27.

引用本文的文献

1
Ventricular arrhythmias and the role of antitachycardia pacing in patients with electrical heart disease and hypertrophic cardiomyopathy.室性心律失常以及抗心动过速起搏在电心脏疾病和肥厚型心肌病患者中的作用。
Int J Cardiol Congenit Heart Dis. 2024 Dec 28;19:100562. doi: 10.1016/j.ijcchd.2024.100562. eCollection 2025 Mar.
2
Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.肥厚型心肌病中心脏性猝死的底物
J Clin Med. 2025 Feb 17;14(4):1331. doi: 10.3390/jcm14041331.
3
Atrial fibrillation and risk of sudden cardiac arrest in young adults.
心房颤动与年轻人心源性猝死风险。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae196.
4
Scar architecture affects the electrophysiological characteristics of induced ventricular arrhythmias in hypertrophic cardiomyopathy.瘢痕结构影响肥厚型心肌病诱导性室性心律失常的电生理特征。
Europace. 2024 Mar 1;26(3). doi: 10.1093/europace/euae050.
5
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator.经静脉或皮下植入除颤器的肥厚型心肌病患者的临床病程。
Europace. 2023 Aug 2;25(9). doi: 10.1093/europace/euad270.
6
Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside.肥厚型心肌病中的室性心律失常与心源性猝死:从实验台到病床边
Front Cardiovasc Med. 2022 Aug 18;9:949294. doi: 10.3389/fcvm.2022.949294. eCollection 2022.
7
Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.左心室肥厚:基于病因的治疗选择。
Cardiol Ther. 2022 Jun;11(2):203-230. doi: 10.1007/s40119-022-00260-y. Epub 2022 Mar 30.
8
Ventricular arrhythmia management in patients with genetic cardiomyopathies.遗传性心肌病患者的室性心律失常管理
Heart Rhythm O2. 2021 Dec 17;2(6Part B):819-831. doi: 10.1016/j.hroo.2021.10.009. eCollection 2021 Dec.
9
Recurrent ventricular fibrillation induced from supraventricular tachycardia in a case of hypertrophic cardiomyopathy.肥厚型心肌病患者室上性心动过速诱发反复心室颤动1例
Indian Pacing Electrophysiol J. 2022 Mar-Apr;22(2):91-93. doi: 10.1016/j.ipej.2021.11.004. Epub 2021 Nov 14.
10
Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy - A nationwide cohort study.肥厚型心肌病患者的心房颤动与心脏性猝死风险——一项全国性队列研究
EClinicalMedicine. 2021 Mar 17;34:100802. doi: 10.1016/j.eclinm.2021.100802. eCollection 2021 Apr.